|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 77, 1-12, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
MS Hochberg, WC Roberts, AG Morrow and WG Austen
The long-term effectiveness of a retrograde coronary venous bypass graft
(CVBG) to an ischemic left ventricle was evaluated in 18 dogs. A saphenous
vein was interposed between the aorta and left anterior descending (LAD)
vein. The LAD vein was ligated cephalad to the CVBG to prevent an
arteriovenous fistula. The LAD artery was ligated at its origin to create
anterior wall ischemia. Operative graft flow averaged 53 ml. per minute.
The 14 surviving dogs were catheterized 3 to 5 months later. Ten of the 14
CVBG's were patent angiographically. The chests were opened and graft flow
now averaged 50 ml. per minute. 141Ce microspheres were injected into the
left atrium to measure myocardial flow to the anterior wall. In the 10 dogs
with patent grafts, transmural flow was 39 +/- 1 (S.E.M.) ml. per 100 Gm.
of tissue per minute. The endocardial/epicardial flow ratio was 1.4/1,
indicating that retrograde venous perfusion effectively delivered blood to
the subendocardium. After ligation of the CVBG, microsphere measured flow
dropped to 15 +/- 1 ml. per 100 Gm. per minute. In 15 control dogs,
anterior wall flow was 100 +/- 3 ml. per 100 Gm. per minute, decreasing to
13 +/- 2 ml. 45 minutes after ligation of the LAD artery and vein. None of
the eight control dogs with simple ligation of the LAD artery and vein
survived more than 5 days. Histologic examination of the anterior wall of
the left ventricle, the area served by the CVBG's for 3 to 5 months,
disclosed no evidence of venous sclerosis or thrombosis and no evidence of
interstitial edema or hemorrhage. Thus a CVBG permitted long-term survival
in an otherwise nonviable anatomic preparation. Moreover, restoration of
flow with a CVBG was effective because it perfused all layers of the
myocardium, especially the subendocardium--the crucial layer of myocardial
muscle.
ARTICLES
Selective arterialization of the coronary venous system. Encouraging long-term flow evaluation utilizing radioactive microspheres
This article has been cited by other articles:
![]() |
M. E. Resetar, C. Ullmann, P. Broeske, K. Ludwig-Schindler, N. K. Doll, A. Salameh, S. Dhein, and F. W. Mohr Selective arterialization of a cardiac vein in a model of cardiac microangiopathy and macroangiopathy in sheep J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1252 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Raake, R. Hinkel, C. Kupatt, M.-L. v. Bruhl, S. Beller, M. Andrees, C. Vicol, and P. Boekstegers Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASSTM): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein Eur. Heart J., June 2, 2005; 26(12): 1228 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, M. A. Borger, and H. E. Scully Aortovenous bypass graft to the posterior left ventricle in absence of an identifiable coronary artery Ann. Thorac. Surg., July 1, 2004; 78(1): 313 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tian, G. Dai, B. Xiang, J. Sun, W. G. Lindsay, and R. Deslauriers Effect on myocardial perfusion of simultaneous delivery of cardioplegic solution through a single coronary artery and the coronary sinus J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Oesterle, N. Reifart, E. Hauptmann, M. Hayase, and A. C. Yeung Percutaneous In Situ Coronary Venous Arterialization : Report of the First Human Catheter-Based Coronary Artery Bypass Circulation, May 29, 2001; 103(21): 2539 - 2543. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |